AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2022 Issue 4; New/Revised ICD-10-PCS Codes Section X – New Technology

Introduction of New Therapeutic Substances

Eleven new substance values were added to code Table XW0, Introduction of Anatomical Regions, for the substances listed below. Please note that all of the substances have a device, substance technology value of 8 New Technology Group 8.Device/Substance/Technology 0 Spesolimab Monoclonal Antibody 1 Daratumumab and Hyaluronidase-fihj 3 Maribavir Anti-infective 4 Teclistamab Antineoplastic 5 Mosunetuzumab Antineoplastic 6 Afamitresgene Autoleucel Immunotherapy 7 Tabelecleucel Immunotherapy 8 Treosulfan 9 Inebilizumab-cdon D Engineered Allogeneic Thymus Tissue X Broad Consortium Microbiota-based Live Biotherapeutic Suspension Spesolimab Monoclonal AntibodyNew ICD-10-PCS codes have been created for the IV administration of Spesolimab into the central or peripheral veins...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .


  • The official AHA publication for ICD-10-CM and ICD-10-PCS coding guidelines and advice
  • Current newsletters added each quarter
  • Full Archives - over 3100 articles
  • ALL years/issues back to 1984 organized by year and issue
  • Includes ICD-10-CM/PCS Articles since 2013
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - ICD-10-CM/PCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.